Gilad E. Gallili

465 citations
12 papers · 359 indexed · h-index 8

Impact in

Papers in

Gilad E. Gallili

12 papers receiving 331 citations

Peers

Gilad E. Gallili
Comparison fields: 5 of 57
  • Animal Science and Zoology 110
  • Infectious Diseases 110
  • Genetics 120
  • Epidemiology 144
  • Agronomy and Crop Science 37
Replace L W Cashdollar with:
L W Cashdollar United States
Gabriela Rebmann Switzerland
Xiaomei Wang China
Donna M. Mulrooney United States
Francisco Perozo United States
Tao Han China
Shahla Shahsavandi Iran
D. Alexander United Kingdom
Jian Ding China
Zongyi Bo China
Gilad E. Gallili relative to L W Cashdollar United States L W Cashdollar's profile →
Citations per field
00.5×10×15×19×
L W Cashdollar · 1×
Citations per year

Countries citing papers authored by Gilad E. Gallili

Since Specialization
Citations

This map shows the geographic impact of Gilad E. Gallili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad E. Gallili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad E. Gallili more than expected).

Fields of papers citing papers by Gilad E. Gallili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilad E. Gallili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad E. Gallili. The network helps show where Gilad E. Gallili may publish in the future.

Co-authors

The 15 scholars most cited alongside Gilad E. Gallili, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilad E. Gallili Line = papers co-authored together Gilad E. Gallili links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 200825
2 20083
3 200523
4 200389
5 200332
6 199864
7 199870
8 19784
9 19784
10 197726
11 19774
12 197415

About Gilad E. Gallili

Gilad E. Gallili is a scholar working on Biotechnology, Animal Science and Zoology, Pharmaceutical Science, Infectious Diseases and Genetics, having authored 12 papers that have together received 359 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Virology and Viral Diseases (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Mosquito-borne diseases and control (2 papers), Animal Genetics and Reproduction (2 papers), Animal Virus Infections Studies (2 papers), Steroid Chemistry and Biochemistry (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Animal Science and Zoology (110 citations), Infectious Diseases (110 citations), Genetics (120 citations), Epidemiology (144 citations) and Agronomy and Crop Science (37 citations). Gilad E. Gallili has collaborated with scholars based in Israel, Netherlands and Czechia. Frequent co-authors include D. Ben‐Nathan, B. Gutter, Jacob Pitcovski, J. O. Lampen, Martin Goldway, B. Perelman, Gideon Gross, D.A. Goldberg, Yuval Peretz and R. I. Máteles. Their work appears in journals such as Vaccine, Avian Pathology, Phytochemistry, Journal of Food Science and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026